483
Geri-Care Pharmaceuticals Corp.FDA 483 - Geri-Care Pharmaceuticals Corp. - May 05, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Geri-Care Pharmaceuticals Corp., an OTC drug repackager and distributor in Lakewood, NJ, was cited for significant quality control deficiencies during an FDA inspection. The firm failed to implement adequate supplier qualification, lacked a written stability program, and did not thoroughly investigate deviations or customer complaints. Additionally, the company did not perform annual visual inspections of reserve drug product samples.
Open in Dashboard
ID · aa1c2161-bd6a-44d7-a584-f3a432a7004e